| Literature DB >> 29097431 |
Pierre-Régis Burgel1,2, Jean-Louis Paillasseur3, Wim Janssens4, Jacques Piquet5, Gerben Ter Riet6, Judith Garcia-Aymerich7, Borja Cosio8, Per Bakke9, Milo A Puhan10, Arnulf Langhammer11, Inmaculada Alfageme12, Pere Almagro13, Julio Ancochea14, Bartolome R Celli15, Ciro Casanova16, Juan P de-Torres17, Marc Decramer4, Andrés Echazarreta18, Cristobal Esteban19, Rosa Mar Gomez Punter20, MeiLan K Han21, Ane Johannessen22, Bernhard Kaiser23, Bernd Lamprecht24, Peter Lange25, Linda Leivseth26, Jose M Marin27, Francis Martin28, Pablo Martinez-Camblor29,30, Marc Miravitlles31, Toru Oga32, Ana Sofia Ramírez33, Don D Sin34, Patricia Sobradillo35, Juan J Soler-Cataluña36, Alice M Turner37, Francisco Javier Verdu Rivera38, Joan B Soriano39, Nicolas Roche40,2.
Abstract
This study aimed to identify simple rules for allocating chronic obstructive pulmonary disease (COPD) patients to clinical phenotypes identified by cluster analyses.Data from 2409 COPD patients of French/Belgian COPD cohorts were analysed using cluster analysis resulting in the identification of subgroups, for which clinical relevance was determined by comparing 3-year all-cause mortality. Classification and regression trees (CARTs) were used to develop an algorithm for allocating patients to these subgroups. This algorithm was tested in 3651 patients from the COPD Cohorts Collaborative International Assessment (3CIA) initiative.Cluster analysis identified five subgroups of COPD patients with different clinical characteristics (especially regarding severity of respiratory disease and the presence of cardiovascular comorbidities and diabetes). The CART-based algorithm indicated that the variables relevant for patient grouping differed markedly between patients with isolated respiratory disease (FEV1, dyspnoea grade) and those with multi-morbidity (dyspnoea grade, age, FEV1 and body mass index). Application of this algorithm to the 3CIA cohorts confirmed that it identified subgroups of patients with different clinical characteristics, mortality rates (median, from 4% to 27%) and age at death (median, from 68 to 76 years).A simple algorithm, integrating respiratory characteristics and comorbidities, allowed the identification of clinically relevant COPD phenotypes.Entities:
Mesh:
Year: 2017 PMID: 29097431 DOI: 10.1183/13993003.01034-2017
Source DB: PubMed Journal: Eur Respir J ISSN: 0903-1936 Impact factor: 16.671